Home
Contact Us Sitemap Workroom
  ALZA 2000 Annual Report
Investor Relations
Sunesis
Threshold
United Commercial Bank (UCBH)
Netflix
Fair, Isaac
Chiron
Onyx
Barra
Solectron
PeopleSoft
ALZA
Caliper Technologies
Aradigm
ProBusiness
Protein Design Labs
Union Bank Foundation
Sangamo BioSciences
The Asia Foundation
The California Endowment
BioTime
 Formative—ALZA Annual Report: ALZA, a drug technology and pharmaceutical company, develops and owns the technologies behind Nicoderm patches, time-released Sudafed, and hundreds of other products sold by pharmaceutical companies around the world. The company also develops and markets its own pharmaceutical products. We've designed annual reports and investor relations materials for ALZA since 1998. ALZA achieved record revenues of $988 million in FY 2000, and was acquired by Johnson & Johnson in 2001.

ALZA 2000 Annual Report - Online
  
 
 
 
© 2013 Formative